In this article, we will look at the 10 Stocks to Buy With Over 50% Upside Potential.
On October 31, Andrew Slimmon, Morgan Stanley Investment Management senior portfolio manager, appeared on CNBC’s “Squawk Box” to talk about the latest market trends.
He stated that the market has begun to exhibit signs of increased speculation. The bull market, according to him, started in October 2022, which means that it is now in the fourth year, with the “rear view” mirror showing making money instead of a bear market.
In such circumstances, as you get later in a bull market, people start to think about how much money they can make instead of how much they can lose, which eventually brings in a speculative element. While the Mag 7 have worked as well, the most speculative, money-losing, non-profitable tech stocks have worked the best since April, which is a warning sign pointing towards a late stage of a bull market.
READ ALSO: 10 Consumer Defensive Stocks With More Than 50% Upside and 14 Stocks Under $5 with Highest Upside Potential.
Therefore, Slimmon believes that the biggest worry is that the market is showing signs of a higher level of speculation, which is consistent with the last stage of a bull market “euphoria”.
With these trends in view, let’s look at the best stocks to buy with over 50% upside potential.
Our Methodology
We used Finviz to compile a list of the best stocks with more than 50% upside and selected the top 10 with the highest analyst upside potential. We also added the number of hedge fund holders as of Q2 2025, sourcing the hedge fund sentiment data from Insider Monkey’s database. The list is sorted in ascending order of analyst upside.
Note: All data was recorded on October 31.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).
10 Stocks to Buy With Over 50% Upside Potential
10. Charter Communications, Inc. (NASDAQ:CHTR)
Analyst Upside: 51.81%
Number of Hedge Fund Holders: 56
Charter Communications, Inc. (NASDAQ:CHTR) is one of the best stocks to buy with over 50% upside potential. Charter Communications, Inc. (NASDAQ:CHTR) reported its fiscal Q3 results on October 31, with total revenue for the quarter declining 0.9% year-over-year to $13.7 billion. Management attributed the drop to lower residential video and advertising sales revenues. Residential connectivity revenue, however, rose 3.8% year-over-year.
The company further reported that net income attributable to Charter shareholders totaled $1.1 billion, while Q3 adjusted EBITDA was $5.6 billion, reflecting a 1.5% year-over-year decline.
The same day, TD Cowen analyst Gregory Williams maintained a buy rating on Charter Communications, Inc. (NASDAQ:CHTR) and set the price target at $428. The analyst told investors that the company has exhibited resilience through its fiscal performance despite looming pressures such as expected EBITDA challenges in fiscal Q4 and broadband subscriber losses.
Williams considers Charter Communications, Inc.’s (NASDAQ:CHTR) in-line EBITDA and revenue announcement to be positive indicators for investors, along with considerable share buybacks and substantial upside in free cash flow.
Charter Communications, Inc. (NASDAQ:CHTR) provides broadband communications services. The company’s offerings include Spectrum TV, Spectrum Internet, and Spectrum Voice. Charter Communications, Inc. (NASDAQ:CHTR) also offers data networking, business-to-business Internet access, video and music entertainment services, business telephone, and wireless backhaul.
9. Wingstop Inc. (NASDAQ:WING)
Analyst Upside: 61.10%
Number of Hedge Fund Holders: 47
Wingstop Inc. (NASDAQ:WING) is one of the best stocks to buy with over 50% upside potential. Wingstop Inc. (NASDAQ:WING) released its fiscal Q3 2025 earnings on November 4, reporting 114 net new openings and a net new unit growth of 19.3%. The company also reported adjusted EBITDA growth of 18.6% to $63.7 million, marking the highest quarter on record for Wingstop Inc. (NASDAQ:WING).
System-wide sales for the quarter rose 10.0% to $1.4 billion, while digital sales grew to 72.8% of system-wide sales. Wingstop Inc. (NASDAQ:WING) further reported a total revenue growth of 8.1% to $175.7 million, while net income reached $28.5 million, or $1.02 per diluted share, reflecting a growth of 10.7%.
The same day, Barclays analyst Jeff Bernstein maintained a bullish stance on the stock, assigning Wingstop Inc. (NASDAQ:WING) a Buy rating with a $330 price target.
Wingstop Inc. (NASDAQ:WING) is a chicken wings-focused restaurant that offers hand-sauced, cooked-to-order, and tossed classic and boneless wings, chicken sandwiches, and tenders in flavors with signature sides.
8. Sprouts Farmers Market, Inc. (NASDAQ:SFM)
Analyst Upside: 64.64%
Number of Hedge Fund Holders: 54
Sprouts Farmers Market, Inc. (NASDAQ:SFM) is one of the best stocks to buy with over 50% upside potential. On October 31, Goldman Sachs analyst Leah Jordan reduced the price target on Sprouts Farmers Market, Inc. (NASDAQ:SFM) to $152 from $178, setting a Buy rating.
The rating came after Sprouts Farmers Market, Inc. (NASDAQ:SFM) reported its fiscal Q3 earnings highlights on October 29, with net sales for the quarter totaling $2.2 billion and reflecting a 13% growth from the prior year period. Comparable store sales experienced a 5.9% growth, while diluted earnings per share reached $1.22, compared to $0.91 in the same period last year.
Sprouts Farmers Market, Inc. (NASDAQ:SFM) opened 9 new stores in the quarter, resulting in 464 stores in 24 US states as of September 28.
Sprouts Farmers Market, Inc. (NASDAQ:SFM) is a specialty natural and organic food retailer that offers a specialty grocery experience. Its products are made of organic, plant-based, gluten-free, and similar lifestyle-friendly ingredients. The company operates around 407 stores in 23 states.
7. QXO, Inc. (NYSE:QXO)
Analyst Upside: 69.78%
Number of Hedge Fund Holders: 65
QXO, Inc. (NYSE:QXO) is one of the best stocks to buy with over 50% upside potential. Truist Financial analyst Keith Hughes reiterated a Buy rating on QXO, Inc. (NYSE:QXO) on October 29.
William Blair analyst Ryan Merkel also maintained a bullish outlook on the stock on October 20, without assigning a price target.
Merkel based the optimistic rating on the company’s potential and performance, stating that QXO, Inc.’s (NYSE:QXO) fiscal Q3 results not only aligned with expectations but also surpassed the broader market expectations. These trends show stable performance amid the challenges of the industry.
The analyst further expects a boost in QXO, Inc.’s (NYSE:QXO) performance by 2026, supported by factors such as improvements in sales execution and pricing, inventory management, and procurement.
QXO, Inc. (NYSE:QXO) distributes roofing, waterproofing, and complementary building products in the United States. The company has plans to become a tech-enabled player in the building products distribution industry.
6. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Analyst Upside: 69.87%
Number of Hedge Fund Holders: 58
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best stocks to buy with over 50% upside potential. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) reported its fiscal Q3 2025 results on October 27. Total revenues for the quarter were $776 million, reflecting a 4% growth compared to the prior year period. This growth was driven by strong revenue growth in VOXZOGO and PALYNZIQ, attributable to new patients initiating therapy across all regions.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) further reported that the year-to-date total revenues rose 11% year-over-year, supported by more than 20% revenue growth for PALYNZIQ and VOXZOGO.
Following the earnings release, J.P. Morgan analyst Jessica Fye reiterated a Buy rating on BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) on October 28, stating that she sees the company’s underlying business to be undervalued.
Despite current market skepticism, the company has potential and a strong base for growth, and holds a strategic market position with considerable capital for business development and a strong pipeline.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) develops and commercializes therapies for serious and life-threatening medical conditions and rare diseases. The company’s product pipeline includes Valoctocogene roxaparvovec, Vosoritide, and BMN 307.
5. Clearwater Analytics Holdings, Inc. (NYSE:CWAN)
Analyst Upside: 71.10%
Number of Hedge Fund Holders: 51
Clearwater Analytics Holdings, Inc. (NYSE:CWAN)is one of the best stocks to buy with over 50% upside potential. Clearwater Analytics Holdings, Inc. (NYSE:CWAN) received a rating update from Oppenheimer analyst Brian Schwartz on October 28. The analyst maintained a Buy rating on the stock and set a price target of $36.
In a separate update, Clearwater Analytics Holdings, Inc. (NYSE:CWAN) and J.P. Morgan Asset Management announced on October 23 an integration transforming the way cash is managed by hedge funds.
Management reported that the solution links Clearwater Analytics Holdings, Inc.’s (NYSE:CWAN) Enfusion “directly with the Morgan Money trading platform, J.P. Morgan Asset Management’s short-term investment management solution, giving clients a single, automated workflow for investing and monitoring idle cash”. Users can select from several currencies, fund providers, and settlement options in one connected experience.
Clearwater Analytics Holdings, Inc. (NYSE:CWAN) provides web-based investment portfolio accounting, reporting, and reconciliation services. The company’s operations are divided into the United States and the Rest of the World geographical segments.
4. On Holding AG (NYSE:ONON)
Analyst Upside: 77.30%
Number of Hedge Fund Holders: 42
On Holding AG’s (NYSE:ONON) is one of the best stocks to buy with over 50% upside potential. On October 28, On Holding AG’s (NYSE:ONON) view was downgraded to Mixed from Positive by BWG Global, who cited checks reflecting softening trends quarter-over-quarter.
Similarly, Goldman Sachs also lowered the price target on On Holding AG (NYSE:ONON) to $50 from $57 while keeping a Neutral rating on the stock. The firm told investors that since the modern market structure is geared more towards DTC and online, it should allow the company to undergo faster revenue scaling compared to Nike or Adidas.
However, the firm added that a longer-term revenue estimate of CHF19B is demanding with a lack of factors such as team sport exposure. Goldman Sachs also adjusted its model to take into account a more negative currency impact of a stronger CHF vs. USD.
On Holding AG (NYSE:ONON) also received a rating update from Raymond James analyst Rick Patel on October 21, who slashed the price target on the stock to $55 from $66 and set an Outperform rating on the stock. The analyst told investors that Softlines and Digital Commerce names are experiencing rising revenue estimates going into Q3, which hints at an improvement in consumer momentum.
Tariff risk is still the key variable according to the analyst, as higher China tariffs may exert pressure on margins in a backdrop where FX shifts provide modest relief to Pound- and Euro- exposed companies.
On Holding AG (NYSE:ONON) is involved in the development and distribution of sports products, including apparel, footwear, and accessories. The company sells its products across the globe through global distributors, independent retailers, an online presence, and its stores.
3. Corcept Therapeutics Incorporated (NASDAQ:CORT)
Analyst Upside: 87.15%
Number of Hedge Fund Holders: 35
Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the best stocks to buy with over 50% upside potential. Canaccord Genuity analyst Edward Nash maintained a Buy rating on Corcept Therapeutics Incorporated (NASDAQ:CORT) on October 21, setting a $140 price target.
Similarly, H.C. Wainwright analyst Swayampakula Ramakanth also maintained a Buy rating on Corcept Therapeutics Incorporated (NASDAQ:CORT) on October 20, and set a $145 price target.
The analyst highlighted the potential of the company’s relacorilant for the treatment of ovarian cancer, stating that the recent ROSELLA trial data, that was presented at the European Society for Medical Oncology congress, reflected promising results for patients with platinum-resistant ovarian cancer previously treated with PARP inhibitors.
Although the subgroup typically has a poorer prognosis, it exhibited considerable progression-free survival benefits upon treatment with relacorilant in combination with nab-paclitaxel.
Ramakanth further stated that management is confident in the broader therapeutic potential of relacorilant, corroborated by the expansion of the BELLA Phase 2 trial to encompass additional indications such as endometrial cancer and platinum-sensitive ovarian cancer.
Corcept Therapeutics Incorporated (NASDAQ:CORT) is a biopharmaceutical company that develops and commercializes therapies that adjust the effects of cortisol, a hormone that regulates various bodily functions. The company’s flagship product, Korlym, is FDA-approved for treating Cushing’s syndrome, a disorder caused by excessive cortisol production.
2. MicroStrategy Incorporated (NASDAQ:MSTR)
Analyst Upside: 99.25%
Number of Hedge Fund Holders: 45
MicroStrategy Incorporated (NASDAQ:MSTR) is one of the best stocks to buy with over 50% upside potential. On October 31, Maxim Group analyst Matthew Galinko reiterated a Buy rating on MicroStrategy Incorporated (NASDAQ:MSTR), bringing the price target down to $425 from $515.
The analyst cited MicroStrategy Incorporated’s (NASDAQ:MSTR) robust bitcoin acquisition strategy and strategic financial maneuvers, stating that the company managed to successfully raise its bitcoin holdings by 5.2% sequentially in fiscal Q3 2025. According to the analyst, this shows effective treasury operations.
Galinko added that MicroStrategy Incorporated (NASDAQ:MSTR) experienced considerable growth in its software business, with a notable 65.4% growth in cloud revenue and a 10.9% year-over-year increase in revenue. The company also has a strong balance sheet, supported by significant digital assets.
MicroStrategy Incorporated (NASDAQ:MSTR) engages in the development of the Bitcoin network through its operations in technology, financial markets, and advocacy. It is the world’s largest corporate holder of Bitcoin.
1. Aurora Innovation, Inc. (NASDAQ:AUR)
Analyst Upside: 129.01%
Number of Hedge Fund Holders: 41
Aurora Innovation, Inc. (NASDAQ:AUR) is one of the best stocks to buy with over 50% upside potential. TD Cowen analyst slashed the price target on Aurora Innovation, Inc. (NASDAQ:AUR) to $5.50 from $7.40 on October 30, and maintained a Hold rating. The firm stated that it sees Q3 as mixed but solidly intact, and remains encouraged by Aurora Innovation, Inc.’s (NASDAQ:AUR) underlying progress.
It is, however, adjusting its model to take into account a more measured 2026-27 revenue ramp to consider timing risks in the validation/launch of the 2nd gen HW fleet.
Separately, Aurora Innovation, Inc. (NASDAQ:AUR) announced on October 28 the rapid expansion of its commercial operations with the launch of a second driverless route from Fort Worth to El Paso. The update comes as the company “surpasses 100,000 driverless miles on public roads and shares its plan to deploy hundreds of driverless trucks with its next-generation Aurora Driver hardware in 2026, fortifying a clear path to meet strong customer demand”.
Management reported that the launch of the 600-mile lane from Fort Worth to El Paso came just six months after the inaugural Dallas to Houston route, which makes it the fastest scaling to a second market in the history of US self-driving.
Aurora Innovation, Inc. (NASDAQ:AUR) designs and develops automobile software and hardware and provides data services. The company also offers the Aurora Driver, an innovative self-driving freight technology that allows a vehicle to drive itself.
While we acknowledge the potential of AUR to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than AUR and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
